Alcohol-Related Liver Disease: The Spectrum from Fatty Liver to Cirrhosis — and What Determines Whether It Can Be Reversed

Alcohol-related liver disease is not a single entity — it is a spectrum, and where a patient sits on that spectrum at the time of first evaluation determines almost everything about prognosis and options. Fatty liver from alcohol can resolve completely with abstinence. Alcohol-related cirrhosis, once established, is permanent. Acute alcoholic hepatitis superimposed on cirrhosis can be fatal within weeks. I am Dr Chetan Kalal, Associate Director — Hepatology and Liver Transplant at Gleneagles Hospital, Mumbai, and I have managed alcohol-related liver disease across the full spectrum.

Alcohol-related liver disease (ALD) spans four stages: fatty liver (steatosis), which is reversible with abstinence; alcoholic steatohepatitis, which is inflammation that may progress to fibrosis; cirrhosis, which is permanent scarring but manageable with the right care; and acute alcoholic hepatitis, a medical emergency carrying up to 30–50% short-term mortality in severe cases. Abstinence is the single most effective intervention at every stage.
— Dr Chetan Kalal, DM Hepatology, Associate Director, Gleneagles Hospital Mumbai

The Four Stages of Alcohol-Related Liver Disease

Stage 1: Fatty Liver (Steatosis)

Fat accumulates in liver cells when the liver prioritises metabolising alcohol over normal fat processing. Almost always asymptomatic, found incidentally on ultrasound. Completely reversible with abstinence — usually within 4–6 weeks of stopping alcohol entirely.

Stage 2: Alcoholic Steatohepatitis

Inflammation is added to fat accumulation. Liver cells begin to die. Fibrosis starts to develop. Still partially reversible in early fibrosis. Some patients have no symptoms; others have right upper quadrant discomfort and elevated liver enzymes.

Stage 3: Cirrhosis

Irreversible scarring has replaced functional liver tissue. The liver’s architecture is distorted. Cirrhosis does not mean the patient will die soon — well-compensated cirrhosis, with abstinence and monitoring, carries reasonable life expectancy. Complications must be actively surveilled.

Stage 4: Acute Alcoholic Hepatitis

An acute severe inflammatory episode — most commonly after a drinking binge in someone with underlying liver disease. Severe acute alcoholic hepatitis (Maddrey Discriminant Function ≥32) is a medical emergency. Mortality in severe cases ranges from 20–50% at 90 days even with treatment.

How Is Alcohol-Related Liver Disease Diagnosed and Staged?

History is the starting point. Accurate alcohol intake history — which requires directness, not euphemism — is the most important clinical data. Biochemically, an AST:ALT ratio greater than 2:1 (in the context of alcohol history) is a classical finding. GGT is the most sensitive enzyme for ongoing alcohol use. Elevated MCV reflects nutritional deficiency and bone marrow suppression from alcohol.

FibroScan (transient elastography) is useful for staging fibrosis non-invasively, though liver stiffness values are significantly elevated during active alcoholic hepatitis regardless of underlying fibrosis — FibroScan during an acute flare overestimates fibrosis and must be interpreted with caution. The Maddrey Discriminant Function (MDF) — calculated from prothrombin time and bilirubin — categorises severity of acute alcoholic hepatitis. An MDF of 32 or above defines severe disease.

Treatment of Alcohol-Related Liver Disease

The Foundation: Abstinence. Abstinence from alcohol is the single most effective intervention at every stage. At fatty liver and early fibrosis, it allows near-complete reversal. In cirrhosis, abstinence significantly slows progression and reduces the risk of decompensation. Nothing else compensates for continued alcohol use.

Nutrition — the Underestimated Pillar. Malnutrition is universal in hospitalised ALD patients. Current evidence supports protein targets of 1.2–1.5 g/kg/day in cirrhotic patients, even those with encephalopathy. Thiamine must be given before glucose in any patient suspected of alcohol dependence — reversing the order risks precipitating Wernicke encephalopathy.

Corticosteroids in Severe Acute Alcoholic Hepatitis. The STOPAH trial (NEJM 2015) established the current standard: prednisolone reduces 28-day mortality in severe acute alcoholic hepatitis (MDF ≥32 or MELD ≥20) but does not improve 90-day survival. Pentoxifylline — previously used — showed no benefit in STOPAH and is no longer recommended. The Lille score at day 7 of steroid therapy determines whether to continue (good response) or stop (non-response).

Transplant for Alcohol-Related Liver Disease

Liver transplantation is an established, guideline-endorsed option for alcohol-related cirrhosis with decompensation. The standard requirement is a minimum six-month period of documented abstinence before listing — not as punishment, but because a meaningful proportion of patients improve sufficiently on abstinence to no longer need transplant, and because abstinence demonstrates capacity for post-transplant compliance.

The six-month rule is evolving. International data supports early transplant in carefully selected patients with severe acute alcoholic hepatitis who have not responded to medical therapy, even without six months of abstinence. We assess each patient individually; there is no blanket policy.

Alcohol-Related Liver Disease Specialist — Mumbai and Maharashtra

Patients with alcohol-related liver disease at any stage are assessed and managed at Gleneagles Hospital, Parel, Mumbai. Referrals are welcome from across Maharashtra and neighbouring states. Urgent slots are available for acute alcoholic hepatitis presentations.

Mumbai
Pune
Nashik
Aurangabad
Nagpur
Kolhapur
Goa
Ahmedabad
Indore

Frequently Asked Questions — Alcohol-Related Liver Disease

My ultrasound shows a fatty liver — do I have cirrhosis?

Not necessarily. Fatty liver on ultrasound is the earliest and most reversible stage of ALD. Cirrhosis has distinct blood test and clinical findings. A hepatology assessment — including FibroScan and blood tests — will determine where on the spectrum you sit.

If I stop drinking now, will my liver recover?

It depends on the stage. Fatty liver: almost certainly yes, within weeks. Early fibrosis: significant improvement is likely over months to years. Cirrhosis: the scarring is permanent, but stopping alcohol markedly improves liver function, reduces portal pressure, and can extend life by years or decades.

What is a safe level of drinking for someone with liver disease?

For a patient with established liver disease, there is no safe level. Even moderate alcohol use accelerates fibrosis progression in someone with pre-existing liver damage. The answer is abstinence, not reduction to a “safe” level.

My family member has acute alcoholic hepatitis in the ICU — what are the realistic outcomes?

Severe acute alcoholic hepatitis carries substantial 90-day mortality even with treatment. If steroids are being given, the Lille score at day 7 indicates whether they are helping. For non-responders, early transplant in selected patients — without waiting for six months of abstinence — is an option at specialist centres and may be discussed if the clinical and psychosocial criteria are met.

Can someone with alcohol-related cirrhosis get a liver transplant in India?

Yes. Alcohol-related cirrhosis is a recognised transplant indication in India, provided the patient meets criteria including documented abstinence, no uncontrolled infection, and psychosocial assessment. Outcomes for well-selected patients are comparable to other indications.

Consultation for Alcohol-Related Liver Disease — Gleneagles Hospital Mumbai

Whether you need staging, a treatment plan, or a transplant evaluation — reach out directly. Urgent slots are available for acute presentations.

OPD: Gleneagles Hospital, Parel, Mumbai — Mon/Wed/Thu/Fri 11 AM–5 PM, Sat 10 AM–1 PM

Written by Dr Chetan Kalal, DM Hepatology (ILBS, New Delhi), Associate Director — Hepatology & Liver Transplant, Gleneagles Hospital Mumbai. 26 PubMed-indexed publications. ORCID: 0000-0002-5284-7890. Last reviewed August 2026.

Book AppointmentDr. Chetan Kalal · Hepatologist